06.13.23 -- 4 Learnings From A Career Of Drug Discovery

Size exclusion chromatography is the go-to analytical method for therapeutic protein drugs. Examine the factors affecting the reproducibility of columns and how you can minimize column variation.

Explore current and emerging technologies to optimize mRNA manufacturing, especially when considering commercial production and the validation of processes in a cGMP environment.

The successful transition from initial synthesis of an API to a kilogram-scale route requires expert analysis and design as well as a balance of economic, regulatory, and time constraints.

Discover the challenges pharma companies are facing as they switch focus as well as the actions and technologies companies are implementing to help achieve a brighter future for patients.

Using volatile processing aids to increase drug solubility in more environmentally friendly solvents such as methanol and reduces the amount of solvent required to manufacture amorphous solid dispersions (ASDs).

Review the process of assay development, qualification, and validation for critical potency assays and how Sartorius supports customers through this vital step.